semaglutide recombinant synthesis Structure of (subcutaneous formulation) Semaglutide (Ozempic and Wegovy) Manufacturing

200 g Fmoc-Gly-Wang Resin (21.6 mmol) with a degree of substitution of 0.108 mmol/g was weighed and swelled for 30 min with DMF, followed by sequentially coupling according to the amino acid sequence of Semaglutide with 2-5 equivalents of amino acid feeds and condensing with DIC+A or B+A+C, until the resin was detected to be transparent with ninhydrin, wherein A was HOBt or HOAt

We can already look at tirzepatide vs semaglutide as an example of how peptide complexity (i.e

GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) are both important hormones released after eating to help regulate your insulin levels, but they have some key differences

In order to achieve the purpose, the technical scheme provided by the invention is as follows: (1) Preparation of compound 2: arg34GLP-1 (9-37) is taken as a starting material, side chain modification is carried out on 26-Lys of the Arg34GLP-1 (9-37) and the compound 1, acylation coupling reaction is carried out under certain reaction pH conditions, and solid is precipitated by adjusting isoelectric point of reaction liquid after post-treatment to obtain a compound 2

Target peak components were collected to obtain refined peptides with a purity of more than 98.5%